Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 525-532
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.525
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.525
Table 1 Consumption of medications
| Major symptoms | No major symptoms | ||
| Frequent | Occasional | ||
| Antacids/alginate | 31.2% | 26.9% | 9.2% |
| Acid inhibitors | 28.2% | 21.5% | 7.2% |
| Aspirin | 40.0% | 40.9% | 45.1% |
| NSAIDs | 29.0% | 30.1% | 22.2% |
- Citation: Bor S, Kitapcioglu G, Kasap E. Prevalence of gastroesophageal reflux disease in a country with a high occurrence of Helicobacter pylori. World J Gastroenterol 2017; 23(3): 525-532
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/525.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.525